We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

Download Mobile App





Clinical Chemistry Analyzer Provides DAU Screening

By LabMedica International staff writers
Posted on 02 Aug 2017
Print article
Image: The EasyRA clinical chemistry system (Photo courtesy of Medica).
Image: The EasyRA clinical chemistry system (Photo courtesy of Medica).
The expanded capability of a clinical chemistry analyzer has been announced to now provide drugs of abuse urine screening (DAU). No hardware or software updates are required, and the added functionality will benefit both current owners and new customers.

EasyRA clinical chemistry analyzer is a fully automated clinical chemistry analyzer that accommodates the diverse needs of small laboratories. The decision to expand the EasyRA’s capabilities into DAU was driven by the call of laboratory and healthcare professionals for a moderately complex, benchtop clinical chemistry analyzer that can also provide urine drug screening.

The EasyRA clinical chemistry system combines moderately complex drugs of abuse and routine chemistry on a single, easy-to-use, moderately complex benchtop analyzer. The EasyRA will offer a panel of drugs of abuse with simply interpreted positive or negative results, to eliminate the need for subjective interpretation in the moderately complex setting. The reagents to enable the new assays are immediately available from Medica’s distribution partners.

Robert Hagopian, BSc, JD, the President, and CEO, Medica Corporation, sad, “Patients and providers will benefit from accurate and cost-effective results when providing pain management treatment, and for applications requiring drugs of abuse screening. This combination of chemistry and DAU screening ability will uniquely position EasyRA users to provide more, faster, and more cost-effective analysis than before. With this announcement, we are continuing to fulfill our commitment to deliver the latest product updates in one convenient installation.” Medica will debut and demonstrate the EasyRA analyzer’s new capability at the annual scientific meeting of the American Association for Clinical Chemistry (AACC), held August 1-3, 2017, in San Diego, CA, USA.

Related Links:
Medica Corporation

Platinum Supplier
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
New
Gold Supplier
HDL Subfractions Kit
Lipoprint HDL Subfractions Kit
New
Enterovirus 71/Coxsackievirus A16/Enterovirus RNA Test
Detection Kit for Enterovirus 71/Coxsackievirus A16/Enterovirus RNA
New
HIV-1 RNA Linearity Panel
AccuSpan HIV-1 RNA Linearity Panel

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.